Effect of hormonal treatment on evolution of endometriomas: An observational study

Ilaria Alasia; Aubert Agostini; Cindy Faust; Julie Berbis; Audrey Pivano

doi:10.1016/j.jogoh.2023.102637

Effect of hormonal treatment on evolution of endometriomas: An observational study

Ilaria Alasia, Aubert Agostini, Cindy Faust, Julie Berbis, Audrey Pivano

Journal of gynecology obstetrics and human reproduction · 2023 · vol. 52(9) , pp. 102637 · doi:10.1016/j.jogoh.2023.102637 · PMID:37527765 · W4385398129

article OA: closed CC0 ⤵ 2 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This observational study investigated the impact of hormonal treatments on the progression of endometriomas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Female Female Female Female Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Association between ovarian endometrioma and ovarian reserve via openalex
Consensus on current management of endometriosis via openalex
Decrease in the size of ovarian endometriomas during ovarian suppression in stage IV endometriosis. Role of preoperative medical treatment. via openalex
Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery? via openalex
Direct proportional relationship between endometrioma size and ovarian parenchyma inadvertently removed during cystectomy, and its implication on the management of enlarged endometriomas via openalex
Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months via openalex
Efficacy of Norethisterone in Patients with Ovarian Endometrioma via openalex
Endometriosis and infertility: pathophysiology and management via openalex
Endometriosis: clinical features, MR imaging findings and pathologic correlation via openalex
Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology via openalex
Findings of Pelvic Endometriosis at Transvaginal US, MR Imaging, and Laparoscopy via openalex
Imaging modalities for the non-invasive diagnosis of endometriosis via openalex
Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study via openalex
Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study via openalex
Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex
Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex
Long-term hormonal treatment reduces repetitive surgery for endometriosis recurrence via openalex
Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
Medical Management of Endometriosis via openalex
Ovarian endometriosis via openalex
Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial via openalex
Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex
Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex
Prevalence of newly diagnosed endometriosis in women attending the general practitioner via openalex
Recommendations for the surgical treatment of endometriosis—part 1: ovarian endometrioma via openalex
Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back via openalex
Serum anti-mullerian hormone in reproductive aged women with benign ovarian cysts via openalex
The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas via openalex
The role of pharmacotherapy in the treatment of endometriosis across the lifespan via openalex
Use of dienogest over 53 weeks for the treatment of endometriosis via openalex
W6704070623 via openalex
W2146098026 via openalex
W6604271678 via openalex
W6645862650 via openalex
W6696413716 via openalex
W2132077126 via openalex

Cited by (2)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-06-04T00:33:39.328528+00:00
unpaywall: last seen: 2026-06-02T02:00:03.124865+00:00

License: CC0 · commercial use OK

[1] Association between ovarian endometrioma and ovarian reserve via openalex

[2] Consensus on current management of endometriosis via openalex

[3] Decrease in the size of ovarian endometriomas during ovarian suppression in stage IV endometriosis. Role of preoperative medical treatment. via openalex

[4] Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery? via openalex

[5] Direct proportional relationship between endometrioma size and ovarian parenchyma inadvertently removed during cystectomy, and its implication on the management of enlarged endometriomas via openalex

[6] Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months via openalex

[7] Efficacy of Norethisterone in Patients with Ovarian Endometrioma via openalex

[8] Endometriosis and infertility: pathophysiology and management via openalex

[9] Endometriosis: clinical features, MR imaging findings and pathologic correlation via openalex

[10] Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology via openalex

[11] Findings of Pelvic Endometriosis at Transvaginal US, MR Imaging, and Laparoscopy via openalex

[12] Imaging modalities for the non-invasive diagnosis of endometriosis via openalex

[13] Incidence and Estimated Prevalence of Endometriosis and Adenomyosis in Northeast Italy: A Data Linkage Study via openalex

[14] Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study via openalex

[15] Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex

[16] Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex

[17] Long-term hormonal treatment reduces repetitive surgery for endometriosis recurrence via openalex

[18] Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex

[19] Medical Management of Endometriosis via openalex

[20] Ovarian endometriosis via openalex

[21] Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial via openalex

[22] Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex

[23] Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex

[24] Prevalence of newly diagnosed endometriosis in women attending the general practitioner via openalex

[25] Recommendations for the surgical treatment of endometriosis—part 1: ovarian endometrioma via openalex

[26] Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back via openalex

[27] Serum anti-mullerian hormone in reproductive aged women with benign ovarian cysts via openalex

[28] The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas via openalex

[29] The role of pharmacotherapy in the treatment of endometriosis across the lifespan via openalex

[30] Use of dienogest over 53 weeks for the treatment of endometriosis via openalex

[31] W6704070623 via openalex

[32] W2146098026 via openalex

[33] W6604271678 via openalex

[34] W6645862650 via openalex

[35] W6696413716 via openalex

[36] W2132077126 via openalex